Biomarkers for dementia: too soon for routine clinical use

Affiliations

¹ Department of Neurology, St George's Hospital, London SW17 0QT, UK; Neurosciences Research Centre, St George's University of London, London, UK. Electronic address: jeremy.isaacs@nhs.net.
² IQ Healthcare, Radboud University Medical Centre, Nijmegen, Netherlands.

Comment

Jeremy D Isaacs et al. Lancet Neurol. 2020 Nov.

. 2020 Nov;19(11):884-885.

doi: 10.1016/S1474-4422(20)30365-3.

¹ Department of Neurology, St George's Hospital, London SW17 0QT, UK; Neurosciences Research Centre, St George's University of London, London, UK. Electronic address: jeremy.isaacs@nhs.net.
² IQ Healthcare, Radboud University Medical Centre, Nijmegen, Netherlands.

No abstract available

Comment on

Amyloid-PET and ¹⁸F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Chételat G, et al. Lancet Neurol. 2020 Nov;19(11):951-962. doi: 10.1016/S1474-4422(20)30314-8. Lancet Neurol. 2020. PMID: 33098804 Review.